Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04887870 |
|
Recruitment Status :
Enrolling by invitation
First Posted : May 14, 2021
Last Update Posted : February 6, 2023
|
Sponsor:
Mirati Therapeutics Inc.
Information provided by (Responsible Party):
Mirati Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | April 19, 2024 |
| Estimated Study Completion Date : | April 19, 2024 |